Hyperlipoproteinemias
"Hyperlipoproteinemias" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation.
Descriptor ID |
D006951
|
MeSH Number(s) |
C18.452.584.500.500.644
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hyperlipoproteinemias".
Below are MeSH descriptors whose meaning is more specific than "Hyperlipoproteinemias".
This graph shows the total number of publications written about "Hyperlipoproteinemias" by people in this website by year, and whether "Hyperlipoproteinemias" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 0 | 1 | 2007 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hyperlipoproteinemias" by people in Profiles.
-
Crispin SM. Lipids and the eye. Vet J. 2016 Jun; 212:90-8.
-
McCrindle BW, Urbina EM, Dennison BA, Jacobson MS, Steinberger J, Rocchini AP, Hayman LL, Daniels SR. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation. 2007 Apr 10; 115(14):1948-67.
-
Plenge JK, Hernandez TL, Weil KM, Poirier P, Grunwald GK, Marcovina SM, Eckel RH. Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation. 2002 Sep 17; 106(12):1447-52.
-
Donahoo WT, Kosmiski LA, Eckel RH. Drugs causing dyslipoproteinemia. Endocrinol Metab Clin North Am. 1998 Sep; 27(3):677-97.
-
Crispin SM. Lipid deposition at the limbus. Eye (Lond). 1989; 3 ( Pt 2):240-50.
-
Schauer UJ, Schauer I. [Lipoprotein metabolism and beta receptor blockers]. Z Gesamte Inn Med. 1987 Apr 15; 42(8):201-5.
-
Holtz H, Heinrich J, D?ck KD, R?hling K, Heller R, Schauer I. [Effectiveness of different intervention measures in children and adolescents with hypertension and lipid metabolism disorders]. Z Gesamte Inn Med. 1983 Dec 01; 38(23):644-9.
-
Daniels SR, Bates S, Lukin RR, Benton C, Third J, Glueck CJ. Cerebrovascular arteriopathy (arteriosclerosis) and ischemic childhood stroke. Stroke. 1982 May-Jun; 13(3):360-5.
-
Falko JM, Williams JC, Harvey DG, Weidman SW, Schonfeld G, Dodson WE. Hyperlipoproteinemia and multifocal neurologic dysfunction in systemic lupus erythematosus. J Pediatr. 1979 Oct; 95(4):523-9.
|
People ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|